| Abstract PR005: TP53 somatic evolution in healthy fallopian tube across the full spectrum of human lifespan R Risques, C Coombes, J Fredrickson, EU Parker, B Kohrn, ... Cancer Research 83 (2_Supplement_1), PR005-PR005, 2023 | | 2023 |
| TP53 mutations in Pap test DNA are a potential biomarker of ovarian cancer risk in high-risk women (226) T Ghezelayagh, J Fredrickson, J Krimmel-Morrison, B Kohrn, M Radke, ... Gynecologic Oncology 166, S125, 2022 | | 2022 |
| Abstract PR005: TP53 field defects in uterine fluid are associated with ovarian cancer risk R Risques, TH Smith, ZK Norgaard, R Katz, FY Lo, EK Schmidt, ... Cancer Research 82 (10_Supplement), PR005-PR005, 2022 | | 2022 |
| Evaluation of TP53 mutations in Pap test and blood DNA as novel biomarkers of ovarian cancer risk T Ghezelayagh, J Fredrickson, J Krimmel-Morrison, B Kohrn, M Radke, ... Gynecologic Oncology 164 (1), 3, 2022 | | 2022 |
| Uterine lavage for the detection of ovarian cancer using an expanded gene panel T Ghezelayagh, J Fredrickson, E Manhardt, M Radke, B Kohrn, H Gray, ... Gynecologic Oncology 164 (1), 8-9, 2022 | | 2022 |
| Evaluation of TP53 mutations in Pap test and blood DNA as novel biomarkers of ovarian cancer risk T Ghezelayagh, J Fredrickson, J Krimmel-Morrison, B Kohrn, M Radke, ... Gynecologic Oncology 162, S153-S154, 2021 | | 2021 |
| Uterine lavage for the detection of ovarian cancer using an expanded gene panel T Ghezelayagh, J Fredrickson, E Manhardt, M Radke, B Kohrn, H Gray, ... Gynecologic Oncology 162, S49, 2021 | 1 | 2021 |
| Characterizing TP53 mutations in ovarian carcinomas with and without concurrent BRCA1 or BRCA2 mutations TS Ghezelayagh, KP Pennington, BM Norquist, N Khasnavis, MR Radke, ... Gynecologic Oncology 160 (3), 786-792, 2021 | 24 | 2021 |
| Telomere-to-telomere assembly of a complete human X chromosome KH Miga, S Koren, A Rhie, MR Vollger, A Gershman, A Bzikadze, ... Nature 585 (7823), 79-84, 2020 | 681 | 2020 |
| Telomere Length is a Susceptibility Marker for Tasmanian Devil Facial Tumor Disease LE Smith, ME Jones, R Hamede, R Risques, AH Patton, PA Carter, ... EcoHealth 17 (3), 280-291, 2020 | 5 | 2020 |
| Characterization of TP53 mutations in Pap test DNA of women with and without serous ovarian cancer. JD Krimmel-Morrison, S Lian, Y Zhang, J Fredrickson, D Nachmanson, ... CLINICAL CANCER RESEARCH 26 (13), 100-101, 2020 | | 2020 |
| Abstract B40: Characterization of TP53 mutations in Pap test DNA of women with and without serous ovarian cancer JD Krimmel-Morrison, S Lian, Y Zhang, J Fredrickson, D Nachmanson, ... Clinical Cancer Research 26 (13 Supplement), B40-B40, 2020 | | 2020 |
| Methods for targeted nucleic acid sequence enrichment with applications to error corrected nucleic acid sequencing SR Kennedy, M Hipp, E Schmidt, RA Risques, D Nachmanson US Patent App. 16/496,936, 2020 | 4 | 2020 |
| Characterization of TP53 mutations in Pap test DNA of women with and without serous ovarian carcinoma JD Krimmel-Morrison, TS Ghezelayagh, S Lian, Y Zhang, J Fredrickson, ... Gynecologic oncology 156 (2), 407-414, 2020 | 11 | 2020 |
| Ovarian cancer detection combining an innovative catheter for uterine and tubal lavage with ultra-sensitive TP53 sequencing P Speiser, E Maritschnegg, F Heitz, N Pecha, J Bouda, F Trillsch, ... International Journal of Gynecologic Cancer 29 (Suppl 4), 2019 | | 2019 |
| Cancer-associated mutations but no cancer: insights into the early steps of carcinogenesis and implications for early cancer detection SR Kennedy, Y Zhang, RA Risques Trends in cancer 5 (9), 531-540, 2019 | 43 | 2019 |
| Winston Timp, Alice Young, James C KH Miga, S Koren, A Rhie, MR Vollger, A Gershman, A Bzikadze, ... Mullikin, Pavel A. Pevzner, Jennifer L. Gerton, Beth A. Sullivan, Evan E …, 2019 | 11* | 2019 |
| Ultra-sensitive TP53 sequencing for cancer detection reveals progressive clonal selection in normal tissue over a century of human lifespan JJ Salk, K Loubet-Senear, E Maritschnegg, CC Valentine, LN Williams, ... Cell reports 28 (1), 132-144. e3, 2019 | 74 | 2019 |
| Duplex Sequencing detects rare subclonal variants that mark early carcinogenesis and preneoplastic clonal evolution CC Valentine, M Fielden, R Young, J Higgins, L Williams, T Li, R Kulkarni, ... Cancer Research 79 (13 Supplement), 4649-4649, 2019 | | 2019 |
| Mitochondrial DNA mutations are associated with ulcerative colitis preneoplasia but tend to be negatively selected in cancer KT Baker, D Nachmanson, S Kumar, MJ Emond, C Ussakli, TA Brentnall, ... Molecular Cancer Research 17 (2), 488-498, 2019 | 30 | 2019 |
